Ocular Surface Disease

This module will cover dry eye disease (including aqueous deficiency and evaporative disease) and focus on diagnosis and treatment of the disease. Conventional methods of diagnosis will be discussed as well as new technology that is available to aid in the diagnosis (osmolarity, topography, mmp9). On the treatment side of things, classic remedies as well as newer ones will be reviewed. Last, certain dangerous entities that can masquerade as dry eye disease will be reviewed, as well as what to do when you’ve tried everything and nothing seems to work.

Learning objectives 

At the end of this session, participants will be able to:

• Compare various technologies in the diagnosis of dry eye/meibomian gland disease
• Know about new treatments in both aqueous deficient and evaporative dry eye (including vitamin A, new artificial tears, contact lenses, antimicrobial agents, and treatment techniques for meibomian gland disease)
• Identify masquerading diagnoses that should not be missed
• Understand the neurogenic pain behind certain patients’ disease and accept that your treatments may not always help

CPD credits This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Ophthalmological Society. Physicians may claim a maximum of 1.5 Section 1 credits. Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 credits. Information on the process to convert Royal College MOC credit to AMA credit. Physicians should only claim credit commensurate with the extent of their participation in the learning activity. INSIGHT was co-developed with Allergan and was planned to achieve scientific integrity, objectivity, and balance. The use of the partner logo is ethically permissible.